GENE ONLINE|News &
Opinion
Blog

Schizophrenia
Otsuka and Lundbeck’s Treatment for Schizophrenia and Bipolar I NDA Accepted by the FDA
2022-09-13
Karuna Therapeutics Announces Topline Results from Schizophrenia Therapy Clinical Trial
2022-08-08
BioXcel Gets FDA Nod for First Oral Sublingual Film for Schizophrenia Treatment
2022-04-08
Transcriptional Programs Uncovering the Genetic Causes of Psychiatric Disorders
2022-03-01
FDA Approves Drug for Schizophrenia in Pediatric Patients
2022-01-10
Janssen’s Long-acting Schizophrenia Drug Notches FDA Approval
2021-09-02
Alkermes Overcomes Regulatory Setbacks to Snag FDA Approval for Schizophrenia Drug
2021-06-01
Neurocrine, Takeda Look to Build on Positives Post Luvadaxistat’s Schizophrenia Trial Failure
2021-03-03
SECUADO – The Hope to Enhance Schizophrenia Patients’ Quality of Life
2019-11-14
Single neurons responsible for error detection and adjustment found
2019-01-03
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top